tm
Seeing Is Believing
tm
Seeing Is Believing
ANTX is currently covered by 5 analysts with an average price target of $9.27. This is a potential upside of $6.95 (299.57%) from yesterday's end of day stock price of $2.32.
AN2 Therapeutics's activity chart (see below) currently has 2 price targets and 15 ratings on display. The stock rating distribution of ANTX is 61.54% BUY and 38.46% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 63.5 days.
Highest price target for ANTX is $27, Lowest price target is $7, average price target is $9.27.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 13-Feb-2024. First documented stock forecast 19-Apr-2022.
Currently out of the existing stock ratings of ANTX, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
7
$4.6 (191.67%)
25
2 months 16 days ago
0/2 (0%)
$3.1 (79.49%)
Hold
7
$4.6 (191.67%)
25
2 months 17 days ago
0/2 (0%)
$1.9 (37.25%)
Hold
30
2 months 17 days ago
0/1 (0%)
$10.66 (55.12%)
Buy
27
$24.6 (1025.00%)
24
7 months 16 days ago
2/4 (50%)
$12.12 (81.45%)
254
What is ANTX (AN2 Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ANTX (AN2 Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ANTX (AN2 Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ANTX (AN2 Therapeutics)?
Which analyst is the currently most bullish on ANTX (AN2 Therapeutics)?
Which analyst is the currently most reserved on ANTX (AN2 Therapeutics)?
